Business
Panbela Therapeutics Releases Promising Data on CPP-1X in Recent Onset Type 1 Diabetes
Panbela Therapeutics, a clinical stage biopharmaceutical company at the forefront of developing disruptive therapeutics for patients facing urgent unmet medical needs, has unveiled groundbreaking preclinical...
Tenon Medical Announces 1:10 Reverse Stock Split, Faces Stock Decline
In a move aimed at reshaping its financial structure, Tenon Medical, a company at the forefront of revolutionizing care for patients afflicted with specific sacroiliac...
BioSig Technologies’ Stock Skyrockets Following Patent Milestone
BioSig Technologies, a leading medical technology company specializing in intracardiac signal visualization, announced a significant milestone today with the reception of multiple new utility patents...
Blue Ridge Bankshares Stock Sees Sharp Decline Following Q3 Financial Report
Blue Ridge Bankshares, the parent company of Blue Ridge Bank, National Association, and BRB Financial Group, has released its financial results for the quarter ending...
Precision BioSciences Stock Rally ahead of Q3 2023 Results
Precision BioSciences, a cutting-edge gene editing company specializing in innovative in vivo gene editing therapies through its proprietary ARCUS® platform, declared today its intention to...
FTC Urged to Examine Exxon Mobil, Chevron Mergers Amidst Antitrust Concerns
US Senate Majority Leader Charles Schumer has voiced apprehensions regarding the recent acquisitions of Exxon Mobil and Chevron Corp., marking them as two of the...
ZyVersa Therapeutics Stock Surges on Breakthrough MS Research
ZyVersa Therapeutics, a clinical stage specialty biopharmaceutical company specializing in the development of first-in-class drugs for the treatment of inflammatory and renal diseases, has announced...
Monopar Therapeutics Stock Surges Ahead of Ongoing ASTS Clinical Trial Data Release
Monopar Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing proprietary therapeutics aimed at enhancing the longevity and quality of life for cancer patients, is set...
Aldeyra Therapeutics’ Stock Surges Over 50 % as Exclusive Option Agreement with AbbVie Unveiled
In a significant development, Aldeyra Therapeutics, a leading biotechnology company specializing in the discovery and development of innovative therapies for immune-mediated diseases, announced today that...
La Rosa Holdings’ Agent Incentive Plan Triggers Market Reaction
La Rosa Holdings, a conglomerate overseeing seven agent-centric, tech-integrated, cloud-based real estate firms, reported on its La Rosa Holdings 2022 Agent Incentive Plan yesterday. The...